MSD Connect Egypt

Login
Register

Related pages

Gastric
KEYNOTE-590:Esophageal
KEYTRUDA® (Pembrolizumab) Selected Safety Information (SSI)

Gastric

KEYNOTE-590: ESOPHAGEAL

SELECTED SAFETY INFORMATION

EG-KEY-00389 | Expiry Date: 24-09-2026

Login

Loading...

Need an account? Register

Privacy Policy
Terms of Use
Contact Us
Sitemap
Accessibility

Copyright© 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

MSD Egypt, 67 - El Tesseen St., Address Building, Fifth Settlement, New Cairo.

In case you need any updates or you have an inquiry or need to report on an adverse reaction, you can contact: Tel.: +2 02 2614 5100 Mail: DPOC_EGYPT@MERCK.COM

This website is maintained by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and is intended for use by individuals who are not residents of the U.S.